SJS Investment Consulting’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-181
Closed -$3.72K – 3253
2026
Q2
$3.72K Buy
+181
New +$4.14K ﹤0.01% 1504
2024
Q2
– Sell
-19
Closed -$499 – 1675
2024
Q1
$499 Buy
19
+1
+6% +$28 ﹤0.01% 1289
2023
Q4
$568 Sell
18
-4
-18% -$109 ﹤0.01% 1204
2023
Q3
$618 Buy
22
+2
+10% +$69 ﹤0.01% 1138
2023
Q2
$738 Sell
20
-6
-23% -$183 ﹤0.01% 1017
2023
Q1
$779 Buy
26
+1
+4% +$33 ﹤0.01% 993
2022
Q4
$766 Buy
25
+10
+67% +$300 ﹤0.01% 1064
2022
Q3
$0 Buy
+15
New +$495 ﹤0.01% 1096

Other funds holding CC

SJS Investment Consulting's CC Position: Q3 2026 in Review

SJS Investment Consulting sold out of Chemours (CC) in Q3 2026, closing a stake of 181 shares — an estimated $3.72K sold.

SJS Investment Consulting first reported a position in CC in Q3 2022 and held it in 8 quarters. The position peaked at $3.72K in Q2 2026. 443 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • SJS Investment Consulting reported no remaining Chemours position as of Q3 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 181 Chemours shares in Q3 2026, an estimated $3.72K.
  • SJS Investment Consulting first reported a position in Chemours in Q3 2022 and held it in 8 quarters.
  • SJS Investment Consulting's Chemours position peaked at $3.72K in Q2 2026.
  • 443 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.